Svenningsson A - Search Results

1

Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction.

Vågberg M, Norgren N, Dring A, Lindqvist T, Birgander R, Zetterberg H, Svenningsson A. Vågberg M, et al. Among authors: svenningsson a. PLoS One. 2015 Aug 28;10(8):e0135886. doi: 10.1371/journal.pone.0135886. eCollection 2015. PLoS One. 2015. PMID: 26317831 Free PMC article.

2

Neurofilament and glial fibrillary acidic protein in multiple sclerosis.

Norgren N, Sundström P, Svenningsson A, Rosengren L, Stigbrand T, Gunnarsson M. Norgren N, et al. Among authors: svenningsson a. Neurology. 2004 Nov 9;63(9):1586-90. doi: 10.1212/01.wnl.0000142988.49341.d1. Neurology. 2004. PMID: 15534240

3

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.

Gunnarsson M, Malmeström C, Axelsson M, Sundström P, Dahle C, Vrethem M, Olsson T, Piehl F, Norgren N, Rosengren L, Svenningsson A, Lycke J. Gunnarsson M, et al. Among authors: svenningsson a. Ann Neurol. 2011 Jan;69(1):83-9. doi: 10.1002/ana.22247. Epub 2010 Dec 8. Ann Neurol. 2011. PMID: 21280078

4

Humoral immune response to influenza vaccine in natalizumab-treated MS patients.

Vågberg M, Kumlin U, Svenningsson A. Vågberg M, et al. Among authors: svenningsson a. Neurol Res. 2012 Sep;34(7):730-3. doi: 10.1179/1743132812Y.0000000059. Epub 2012 Jun 16. Neurol Res. 2012. PMID: 22709910

5

Automated determination of brain parenchymal fraction in multiple sclerosis.

Vågberg M, Lindqvist T, Ambarki K, Warntjes JB, Sundström P, Birgander R, Svenningsson A. Vågberg M, et al. Among authors: svenningsson a. AJNR Am J Neuroradiol. 2013 Mar;34(3):498-504. doi: 10.3174/ajnr.A3262. Epub 2012 Sep 13. AJNR Am J Neuroradiol. 2013. PMID: 22976234 Free PMC article.

6

Fatal neuroinflammation in a case of multiple sclerosis with anti-natalizumab antibodies.

Svenningsson A, Dring AM, Fogdell-Hahn A, Jones I, Engdahl E, Lundkvist M, Brännström T, Gilthorpe JD. Svenningsson A, et al. Neurology. 2013 Mar 5;80(10):965-7. doi: 10.1212/WNL.0b013e3182840be3. Epub 2013 Feb 6. Neurology. 2013. PMID: 23390173 No abstract available.

7

Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.

Khademi M, Dring AM, Gilthorpe JD, Wuolikainen A, Al Nimer F, Harris RA, Andersson M, Brundin L, Piehl F, Olsson T, Svenningsson A. Khademi M, et al. Among authors: svenningsson a. PLoS One. 2013 May 7;8(5):e63172. doi: 10.1371/journal.pone.0063172. Print 2013. PLoS One. 2013. PMID: 23667585 Free PMC article.

8

Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis.

Axelsson M, Malmeström C, Gunnarsson M, Zetterberg H, Sundström P, Lycke J, Svenningsson A. Axelsson M, et al. Among authors: svenningsson a. Mult Scler. 2014 Jan;20(1):43-50. doi: 10.1177/1352458513490544. Epub 2013 May 23. Mult Scler. 2014. PMID: 23702432

9

Lumbar puncture preferences among Swedish neurologists.

Salzer J, Sundström P, Vågberg M, Svenningsson A. Salzer J, et al. Among authors: svenningsson a. Neurol Res. 2015 Jan;37(1):92-4. doi: 10.1179/1743132814Y.0000000442. Epub 2014 Sep 12. Neurol Res. 2015. PMID: 25213597

10

MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study.

Svenningsson A, Sundstrom P, Salzer J, Vagberg M. Svenningsson A, et al. Neurology. 2014 Nov 25;83(22):2099-100. doi: 10.1212/01.wnl.0000457455.74798.9a. Neurology. 2014. PMID: 25422402 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page